SCHEMBL7428711

SCHEMBL7428711

COC(=O)c1cc(C)c2c(CCc3cc(=O)[nH]c(N)n3)n[nH]c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 3/20 0.43
▸ PARP1 P09874 2/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ HPGD P15428 3/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ TSHR P16473 2/20 0.34
▸ USP2 O75604 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ MAPT P10636 3/20 0.33
▸ GAA P10253 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ TP53 P04637 1/20 0.32
▸ ABL1 P00519 1/20 0.32
▸ RIN1 Q13671 1/20 0.32
▸ XDH P47989 1/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7423380 0.76 ALDH1A1 (0.39) PARP1SMN1; SMN2HPGDMAPTGAA
SCHEMBL7421945 0.75 PARP1 (0.36) PARP1MAPK1MAPTGAAXDH
SCHEMBL7425752 0.71 KDM4E (0.36) PARP1SMN1; SMN2KMT2AMEN1PKM
SCHEMBL13908143 0.68 PNP (0.43) SMN1; SMN2HPGDKMT2ATSHRUSP2
SCHEMBL4809195 0.63 BACE1 (1.00) BACE1SMN1; SMN2HPGDKMT2AMAPT
SCHEMBL13907978 0.62 BCL6 (0.45) PARP1HPGDMAPTGAAXDH
SCHEMBL6170448 0.60 KDM4E (0.45) SMN1; SMN2HPGDGAAXDHALDH1A1
SCHEMBL159894 0.60 ACACB (0.43) SMN1; SMN2KMT2AMEN1MAPK1MAPT
SCHEMBL2403638 0.59 BACE1 (0.73) BACE1SMN1; SMN2ABL1RIN1XDH
SCHEMBL9242061 0.59 BACE1 (0.78) BACE1KMT2AABL1RIN1XDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054871-A2 PYRIMIDINES AND TRIAZINES AS INTEGRIN ANTAGONISTS Du Pont Pharmaceuticals Company (US) 2000-11-29 — — EP disclosed
WO-1999050249-A2 PYRIMIDINES AND TRIAZINES AS INTEGRIN ANTAGONISTS DU PONT PHARMACEUTICALS COMPANY (US) 1999-10-07 — — WO disclosed
Send feedback